Journal article
Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy
Molecular cancer, Vol.21(1), pp.27-27
01/21/2022
DOI: 10.1186/s12943-021-01486-5
PMCID: PMC8780708
PMID: 35062950
Abstract
Cellular metabolism constitutes a fundamental process in biology. During tumor initiation and progression, each cellular component in the cancerous niche undergoes dramatic metabolic reprogramming, adapting to a challenging microenvironment of hypoxia, nutrient deprivation, and other stresses. While the metabolic hallmarks of cancer have been extensively studied, the metabolic states of the immune cells are less well elucidated. Here we review the metabolic disturbance and fitness of the immune system in the tumor microenvironment (TME), focusing on the impact of oncometabolites to the function of immune cells and the clinical significance of targeting metabolism in anti-tumor immunotherapy. Metabolic alterations in the immune system of TME offer novel therapeutic insight into cancer treatment.
Details
- Title: Subtitle
- Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy
- Creators
- Xin Lian - Sichuan UniversityKailin Yang - Cleveland ClinicRenliang Li - Sichuan UniversityMaomao Li - Sichuan UniversityJing Zuo - West China Medical Center of Sichuan UniversityBohao Zheng - Sichuan UniversityWei Wang - Sichuan UniversityPing Wang - Sichuan UniversityShengtao Zhou - Sichuan University
- Resource Type
- Journal article
- Publication Details
- Molecular cancer, Vol.21(1), pp.27-27
- DOI
- 10.1186/s12943-021-01486-5
- PMID
- 35062950
- PMCID
- PMC8780708
- ISSN
- 1476-4598
- eISSN
- 1476-4598
- Grant note
- T32 CA094186 / NCI NIH HHS
- Language
- English
- Date published
- 01/21/2022
- Academic Unit
- Radiation Oncology
- Record Identifier
- 9984696568402771
Metrics
3 Record Views